Rieke E Alten
45PUBLICATIONS
95CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (45)
Sort by Publication Date:
|Jan 12, 2026
Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA).Georg Pongratz, Rieke Alten, Torsten Witte
|Dec 23, 2025
Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.Rieke Alten, Andrew Östör, Christopher J Edwards
|Jan 30, 2025
Safety and efficacy of filgotinib in patients with rheumatoid arthritis: final results of the DARWIN 3 long-term extension study.Rene Westhovens, Kevin L Winthrop, Arthur Kavanaugh
|Sep 21, 2024
Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study.Lars Erik Kristensen, Khai Jing Ng, Marcus Ngantcha
|Mar 13, 2024
Impact of filgotinib on pain control in the phase 3 FINCH studies.Peter C Taylor, Arthur Kavanaugh, Peter Nash
|Jan 10, 2024
What benefit-risk trade-offs are acceptable to rheumatoid arthritis patients during treatment selection? Evidence from a multicountry choice experiment.Rieke Alten, Juan Carlos Nieto-Gonzalez, Peggy Jacques
Pageof 8
Frequent Collaborators
5 joint publications
Rene Westhovens
4 joint publications
Mark C Genovese
3 joint publications
Peter C Taylor
3 joint publications
Steven Simoens
3 joint publications
Ji Hoon Jeong
2 joint publications
Zsombor Zrubka
2 joint publications
Valentin Brodszky
2 joint publications
Zoltán Szekanecz
2 joint publications
Márta Péntek
2 joint publications
Jonas Halfvarson
